Evaluating the Differential Effects of Valproic Acid on Wharton's Jelly Mesenchymal Stem Cells

Purpose: The histone deacetylases (HDAC) inhibitor, valproic acid (VPA), is a common antiepileptic drug and is attractive for its broad range of therapeutic effects on many diseases. It has been employed as an inducer of pluripotency in some cultured cells. Conversely, VPA has also been employed as...

Full description

Saved in:
Bibliographic Details
Main Authors: Homa Salami (Author), Seyed Javad Mowal (Author), Rasoul Moukhah (Author), Zahra Hajebrahimi (Author), Seyed Abdolhakim Hosseini (Author), Houri Edalat (Author)
Format: Book
Published: Tabriz University of Medical Sciences, 2019-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_afcd43adb1fb4d2b8e5f0c38a3346fc7
042 |a dc 
100 1 0 |a Homa Salami  |e author 
700 1 0 |a Seyed Javad Mowal  |e author 
700 1 0 |a Rasoul Moukhah  |e author 
700 1 0 |a Zahra Hajebrahimi  |e author 
700 1 0 |a Seyed Abdolhakim Hosseini  |e author 
700 1 0 |a Houri Edalat  |e author 
245 0 0 |a Evaluating the Differential Effects of Valproic Acid on Wharton's Jelly Mesenchymal Stem Cells 
260 |b Tabriz University of Medical Sciences,   |c 2019-08-01T00:00:00Z. 
500 |a 2228-5881 
500 |a 2251-7308 
500 |a 10.15171/apb.2019.059 
520 |a Purpose: The histone deacetylases (HDAC) inhibitor, valproic acid (VPA), is a common antiepileptic drug and is attractive for its broad range of therapeutic effects on many diseases. It has been employed as an inducer of pluripotency in some cultured cells. Conversely, VPA has also been employed as an inducer of in vitro differentiation in many other cells. Therefore, we employed WJMSCs as a cellular target to evaluate the differential effects of of VPA on potency state and differentiation level of Wharton's Jelly mesenchymal stem cells (WJMSCs) in various concentrations and different culture mediums. Methods: The isolated WJMSCs were cultured in DMEM (MSC medium). According to previous protocols, WJMSCs were treated with 0, 0.5 and 1 mM VPA in MSC or embryonic stem cell (ESC) medium and 2 mM VPA in neural differentiation medium. Real-time polymerase chain reaction (PCR) and western blot analysis were performed for evaluating the expression of pluripotency markers. MTT and caspase assays were also performed on VPA-treated cells. Results: The expression of pluripotency markers and the viability of the WJMSCs - determined by MTT assay - were significantly increased after 0.5 mM VPA treatment in ESC medium. A 2 mM VPA treatment in neural differentiation medium significantly diminished the expression of pluripotency markers and the viability of WJMSCs. Conclusion: According to our results, both VPA concentration and the medium context can influence VPA effects on WJMSCs. The differential effects of VPA on WJMSCs can reflect its wide range of effects in the treatment of various diseases. 
546 |a EN 
690 |a Valproic acid 
690 |a Wharton's jelly mesenchymal stem cells 
690 |a Potency 
690 |a Neural differentiation 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Advanced Pharmaceutical Bulletin, Vol 9, Iss 3, Pp 497-504 (2019) 
787 0 |n https://apb.tbzmed.ac.ir/PDF/apb-26465 
787 0 |n https://doaj.org/toc/2228-5881 
787 0 |n https://doaj.org/toc/2251-7308 
856 4 1 |u https://doaj.org/article/afcd43adb1fb4d2b8e5f0c38a3346fc7  |z Connect to this object online.